Ensysce Biosciences, Inc. (ENSC) Net margin 2020–2025
Ensysce Biosciences, Inc. (ENSC) net profit margin by fiscal year — reported net income divided by reported revenue.
-200.8%FY2025 · since FY2020: 109.7% → -200.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -200.8% | -47.5 pp |
| FY2024 | -153.3% | +323.1 pp |
| FY2023 | -476.4% | +482.9 pp |
| FY2022 | -959.3% | -134.0 pp |
| FY2021 | -825.4% | -935.0 pp |
| FY2020 | 109.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice